Asad Bashey

Asad Bashey

UNVERIFIED PROFILE

Are you Asad Bashey?   Register this Author

Register author
Asad Bashey

Asad Bashey

Publications by authors named "Asad Bashey"

Are you Asad Bashey?   Register this Author

77Publications

2593Reads

38Profile Views

Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and Efficacy.

Biol Blood Marrow Transplant 2019 Nov 25;25(11):2211-2216. Epub 2019 Jun 25.

The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.017DOI Listing
November 2019

Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?

Biol Blood Marrow Transplant 2019 Oct 4;25(10):2054-2060. Epub 2019 Jun 4.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.031DOI Listing
October 2019

Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program.

Bone Marrow Transplant 2019 Sep 16. Epub 2019 Sep 16.

Leukemia/Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0675-1DOI Listing
September 2019

Safety and efficacy of rituximab-based first line treatment of chronic GVHD.

Bone Marrow Transplant 2019 Aug 5;54(8):1218-1226. Epub 2018 Dec 5.

The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0399-7
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0399-7DOI Listing
August 2019

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 03 19;25(3):606-612. Epub 2018 Sep 19.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183056
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.012DOI Listing
March 2019

Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.

Bone Marrow Transplant 2018 05 15;53(5):576-583. Epub 2018 Jan 15.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-017-0076-2DOI Listing
May 2018

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 05 2;18(5):346-352.e5. Epub 2018 Mar 2.

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, Moores Cancer Center, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.017DOI Listing
May 2018

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

J Clin Oncol 2017 Sep 23;35(26):3002-3009. Epub 2017 Jun 23.

Asad Bashey, Melhem Solh, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA; Mei-Jie Zhang, Andrew St. Martin, Trevor Argall, Mehdi Hamadani, and Mary Eapen, Medical College of Wisconsin, Milwaukee, WI; Shannon R. McCurdy and Ephraim Joseph Fuchs, The Johns Hopkins Hospital, Baltimore, MD; Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Stefan O. Ciurea, MD Anderson Cancer Center, Houston, TX; Omotayo Fasan, The Center for Bone Marrow Transplantation at Geisinger Medical Center, Danville; Sameh Gaballa, Thomas Jefferson University Hospital, Philadelphia, PA; Pashna Munshi and Scott Rowley, MedStar Georgetown University Hospital, Washington, DC; Monzr M. Al Malki and Ryotaro Nakamura, City of Hope National Medical Center, Duarte, CA; Paul V. O'Donnell, Massachusetts General Hospital; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Miguel-Angel Perales, Memorial Sloan Kettering Cancer Center, New York, NY; Kavita Raj, King's College Hospital, London; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Rizwan Romee, Barnes Jewish Hospital, St Louis, MO; Scott Rowley, Hackensack University Medical Center, Hackensack, NJ; and Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590802PMC
September 2017

Current Graft-versus-Host Disease-Free, Relapse-Free Survival: A Dynamic Endpoint to Better Define Efficacy after Allogenic Transplant.

Biol Blood Marrow Transplant 2017 Jul 5;23(7):1208-1214. Epub 2017 Apr 5.

The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.02.022DOI Listing
July 2017

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.

Haematologica 2017 05 25;102(5):941-947. Epub 2017 Jan 25.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.158584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477613PMC
May 2017

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2017 Feb 14;23(2):318-324. Epub 2016 Nov 14.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517662PMC
February 2017

Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.

Biol Blood Marrow Transplant 2016 10 21;22(10):1816-1822. Epub 2016 Jul 21.

The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.07.010DOI Listing
October 2016

Extramedullary acute myelogenous leukemia.

Blood Rev 2016 09 8;30(5):333-9. Epub 2016 Apr 8.

The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2016.04.001DOI Listing
September 2016

Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center.

Biol Blood Marrow Transplant 2016 08 14;22(8):1403-1409. Epub 2016 Apr 14.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.04.006DOI Listing
August 2016

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

N Engl J Med 2016 Jul;375(2):143-53

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School (M.S.D., H.T.K., P.B., R.L., A.S., A.P.L., M.H., M.S., F.S.H., C.J.W., V.T.H., C. Cutler, J.K., E.P.A., J.H.A., P.A., J.R., R.J.S.), the Bone Marrow Transplant Program, Beth Israel Deaconess Medical Center and Harvard Medical School (D.A.), the Bone Marrow Transplant Program, Massachusetts General Hospital Cancer Center and Harvard Medical School (Y.-B.C.), the Departments of Dermatology (N.R.L.) and Pathology (S.R.G., J.L.H., S.J.R.), Dana-Farber and Brigham and Women's Cancer Center, and the Dana-Farber Cancer Institute, Center for Molecular Oncologic Pathology (M.B., C.W.Z.) - all in Boston; Broad Institute of Massachusetts Institute of Technology and Harvard (P.B., C.J.W.) and Neon Therapeutics (M.S.R.) - both in Cambridge; the Blood and Marrow Transplant Program, University of California, San Diego, Moores Cancer Center, La Jolla (C. Costello, E.D.B.); Colorado Blood Cancer Institute, Denver (P.M.); Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (H.S.); and the Blood and Marrow Transplant Group of Georgia at Northside Hospital, Atlanta (A.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1601202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149459PMC
July 2016

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide.

Adv Hematol 2016 21;2016:9736564. Epub 2016 Jan 21.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA 30342, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/9736564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745340PMC
February 2016

Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.

Biol Blood Marrow Transplant 2015 Sep 16;21(9):1576-82. Epub 2015 May 16.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.04.023DOI Listing
September 2015

Peripheral blood stem cells for T cell-replete nonmyeloablative hematopoietic transplants using post-transplant cyclophosphamide.

Authors:
Asad Bashey

Biol Blood Marrow Transplant 2014 May 15;20(5):598-9. Epub 2014 Mar 15.

Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.03.009DOI Listing
May 2014

Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.

Biol Blood Marrow Transplant 2009 Oct 3;15(10):1306-13. Epub 2009 Aug 3.

Department of Medicine, University of California, San Diego, La Jolla, California 92093-0960, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.06.006DOI Listing
October 2009

Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.

Leuk Res 2006 Apr 21;30(4):503-6. Epub 2005 Nov 21.

Department of Medicine, University of California, San Diego, 9500 Gilman Dr, Mail Code 0960, La Jolla, CA 92093-0960, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.09.002DOI Listing
April 2006

Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic cell transplantation.

Authors:
Asad Bashey

Cancer Treat Res 2002 ;110:39-49

Blood and Marrow Transplantation Division, University of California San Diego, Department of Medicine, UCSD Cancer Center, La Jolla, CA 92093-0960, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4615-0919-6_2DOI Listing
August 2002

Adenovirus transduction to effect CD40 signalling improves the immune stimulatory activity of myeloma cells.

Br J Haematol 2002 Aug;118(2):506-13

Division of Blood and Marrow Transplantation, Department of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0663, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03603.xDOI Listing
August 2002